| Primary |
| Diuretic Therapy |
50.0% |
| Blood Potassium Decreased |
16.7% |
| Electrolyte Substitution Therapy |
16.7% |
| Hypokalaemia |
16.7% |
|
| Blood Potassium Increased |
16.7% |
| Hypokalaemia |
16.7% |
| Palpitations |
16.7% |
| Pharmaceutical Product Complaint |
16.7% |
| Pruritus |
16.7% |
| Weight Decreased |
16.7% |
|
| Secondary |
| Blood Pressure |
44.4% |
| Convulsion |
11.1% |
| Oedema |
11.1% |
| Diuretic Therapy |
7.4% |
| Hypokalaemia |
7.4% |
| Osteoporosis |
7.4% |
| Atrial Fibrillation |
3.7% |
| Blood Potassium Decreased |
3.7% |
| Hypotension |
3.7% |
|
| Hypertension |
37.5% |
| Dehydration |
12.5% |
| Night Sweats |
12.5% |
| Rash |
12.5% |
| Visual Impairment |
12.5% |
| Weight Decreased |
12.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
41.1% |
| Drug Use For Unknown Indication |
7.3% |
| Hypertension |
4.5% |
| Parkinson's Disease |
4.1% |
| Pain |
3.9% |
| Pulmonary Hypertension |
3.9% |
| Constipation |
3.7% |
| Pulmonary Arterial Hypertension |
3.2% |
| Anxiety |
3.0% |
| Asthma |
3.0% |
| Multiple Myeloma |
2.8% |
| Nausea |
2.6% |
| Osteoporosis |
2.6% |
| Blood Cholesterol Increased |
2.4% |
| Diabetes Mellitus |
2.4% |
| Atrial Fibrillation |
1.9% |
| Cardiac Disorder |
1.9% |
| Headache |
1.9% |
| Helicobacter Infection |
1.9% |
| Plasma Cell Myeloma |
1.9% |
|
| Death |
8.3% |
| Rectal Haemorrhage |
6.7% |
| Swelling |
6.7% |
| Vomiting |
6.7% |
| Abdominal Pain |
5.0% |
| Convulsion |
5.0% |
| Drug Hypersensitivity |
5.0% |
| Dyspnoea |
5.0% |
| Malaise |
5.0% |
| Pathological Gambling |
5.0% |
| Pneumonia |
5.0% |
| Pruritus |
5.0% |
| Pulmonary Embolism |
5.0% |
| Tremor |
5.0% |
| Weight Decreased |
5.0% |
| Blood Potassium Decreased |
3.3% |
| Deep Vein Thrombosis |
3.3% |
| Drug Ineffective |
3.3% |
| Fall |
3.3% |
| Injection Site Pain |
3.3% |
|
